Corrigendum: Chronic Exposure to Malaria Is Associated with Inhibitory and Activation Markers on Atypical Memory B Cells and Marginal Zone-Like B Cells by Ubillos, Itziar & Requena, Pilar
CORRECTION
published: 17 October 2019
doi: 10.3389/fimmu.2019.02427
Frontiers in Immunology | www.frontiersin.org 1 October 2019 | Volume 10 | Article 2427
Approved by:
Frontiers Editorial Office,





This article was submitted to
B Cell Biology,
a section of the journal
Frontiers in Immunology
Received: 27 September 2019
Accepted: 27 September 2019
Published: 17 October 2019
Citation:
Ubillos I, Campo JJ, Requena P,
Ome-Kaius M, Hanieh S, Rose H,
Samol P, Barrios D, Jiménez A,
Bardají A, Mueller I, Menéndez C,
Rogerson S, Moncunill G and
Dobaño C (2019) Corrigendum:
Chronic Exposure to Malaria Is
Associated with Inhibitory and
Activation Markers on Atypical




Corrigendum: Chronic Exposure to
Malaria Is Associated with Inhibitory
and Activation Markers on Atypical
Memory B Cells and Marginal
Zone-Like B Cells
Itziar Ubillos 1, Joseph J. Campo 1,2, Pilar Requena 1,3, Maria Ome-Kaius 4, Sarah Hanieh 4,
Honor Rose 4, Paula Samol 4, Diana Barrios 1, Alfons Jiménez 1,5, Azucena Bardají 1,
Ivo Mueller 4,6, Clara Menéndez 1, Stephen Rogerson 7, Gemma Moncunill 1 and
Carlota Dobaño 1*
1 ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain, 2 Antigen
Discovery Inc., Irvine, CA, United States, 3 Facultad de Medicina, Universidad de Granada, Granada, Spain, 4 Papua New
Guinea Institute of Medical Research, Madang, Papua New Guinea, 5CIBER Epidemiology and Public Health (CIBERESP),
Barcelona, Spain, 6Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, 7University of Melbourne,
Melbourne, VIC, Australia
Keywords: chronic infection, malaria, tolerance, B cells, host–malaria interaction
A Corrigendum on
Chronic Exposure toMalaria Is Associated with Inhibitory and ActivationMarkers on Atypical
Memory B Cells and Marginal Zone-Like B Cells
by Ubillos, I., Campo, J. J., Requena, P., Ome-Kaius, M., Hanieh, S., Rose, H., et al. (2017). Front.
Immunol. 8:966. doi: 10.3389/fimmu.2017.00966
In the original article, we neglected to include the co-funder “FEDER funds/European Regional
Development Fund (ERDF)” to “Instituto de Salud Carlos III (grant number PI14/01422)”.
A correction has been made to the Funding statement:
“This work was funded by the Instituto de Salud Carlos III (grant number PI14/01422),
cofunded by FEDER funds/European Regional Development Fund (ERDF), the EU FP7 (PregVax,
FP7/2007–2013 Grant 201588), the Ministerio de Economía y Competitividad (National R&D
Internationalization Program, EUROSALUD 2008, Grant EUS2009-03560), and the Malaria in
Pregnancy Consortium through the Bill & Melinda Gates Foundation (Grant 46099). GM was
recipient of a Sara Borrell—ISCIII fellowship (CD010/00156). CD was supported by a fellowship
from the Ministerio de Economía y Competitividad (Grant RYC-2008-02631) and was affiliate of
the EU FP7 Network of Excellence EviMalaR. IU received funds from EviMalaR and the Agency for
Management of University and Research Grants (AGAUR grant number 2014SGR991) for doctoral
studies. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya.”
The authors apologize for this error and state that this does not change the scientific conclusions
of the article in any way. The original article has been updated.
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